Annual EBITDA
-$29.43 M
+$13.46 M+31.38%
31 December 2023
Summary:
Telesis Bio annual earnings before interest, taxes, depreciation & amortization is currently -$29.43 million, with the most recent change of +$13.46 million (+31.38%) on 31 December 2023. During the last 3 years, it has fallen by -$31.96 million (-1263.44%). TBIO annual EBITDA is now -1263.44% below its all-time high of $2.53 million, reached on 01 December 2020.TBIO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$9.53 M
-$2.28 M-31.53%
30 June 2024
Summary:
Telesis Bio quarterly earnings before interest, taxes, depreciation & amortization is currently -$9.53 million, with the most recent change of -$2.28 million (-31.53%) on 30 June 2024. Over the past year, it has dropped by -$816.00 thousand (-9.37%). TBIO quarterly EBITDA is now -130.06% below its all-time high of $31.70 million, reached on 01 September 2020.TBIO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$28.79 M
-$2.88 M-11.11%
30 June 2024
Summary:
Telesis Bio TTM earnings before interest, taxes, depreciation & amortization is currently -$28.79 million, with the most recent change of -$2.88 million (-11.11%) on 30 June 2024. Over the past year, it has increased by +$3.45 million (+10.71%). TBIO TTM EBITDA is now -155.57% below its all-time high of $51.80 million, reached on 01 June 2021.TBIO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TBIO EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.4% | -9.4% | +10.7% |
| 3 y3 years | -1263.4% | -139.9% | -155.6% |
| 5 y5 years | +61.5% | +56.5% | +66.8% |
TBIO EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1263.4% | +31.4% | -139.9% | +31.2% | -155.6% | +31.4% |
| 5 y | 5 years | -1263.4% | +68.2% | -130.1% | +64.3% | -155.6% | +69.3% |
| alltime | all time | -1263.4% | +68.2% | -130.1% | +64.3% | -155.6% | +69.3% |
Telesis Bio EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$9.53 M(+31.5%) | -$28.79 M(+11.1%) |
| Mar 2024 | - | -$7.24 M(+118.9%) | -$25.91 M(-9.2%) |
| Dec 2023 | -$29.43 M(-31.4%) | -$3.31 M(-62.0%) | -$28.54 M(-11.5%) |
| Sept 2023 | - | -$8.71 M(+31.0%) | -$32.24 M(-7.3%) |
| June 2023 | - | -$6.65 M(-32.6%) | -$34.78 M(-17.2%) |
| Mar 2023 | - | -$9.87 M(+40.6%) | -$41.98 M(+30.7%) |
| Dec 2022 | -$42.90 M(+26.7%) | -$7.02 M(-37.6%) | -$32.11 M(+28.0%) |
| Sept 2022 | - | -$11.24 M(-18.8%) | -$25.10 M(+81.2%) |
| June 2022 | - | -$13.85 M(-158.0%) | -$13.85 M(-126.7%) |
| Dec 2021 | -$33.86 M(-1438.4%) | - | - |
| June 2021 | - | $23.88 M(-264.5%) | $51.80 M(+375.0%) |
| Mar 2021 | - | -$14.52 M(-235.1%) | $10.91 M(+331.1%) |
| Dec 2020 | $2.53 M | $10.74 M(-66.1%) | $2.53 M(-107.2%) |
| Sept 2020 | - | $31.70 M(-286.2%) | -$34.92 M(-60.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | -$17.02 M(-25.7%) | -$88.53 M(-5.7%) |
| Mar 2020 | - | -$22.89 M(-14.3%) | -$93.88 M(+1.5%) |
| Dec 2019 | -$92.47 M(+21.1%) | -$26.70 M(+21.8%) | -$92.47 M(+6.6%) |
| Sept 2019 | - | -$21.92 M(-2.0%) | -$86.71 M(+4.5%) |
| June 2019 | - | -$22.37 M(+4.1%) | -$82.97 M(+2.6%) |
| Mar 2019 | - | -$21.48 M(+2.5%) | -$80.90 M(+5.9%) |
| Dec 2018 | -$76.37 M(+27.8%) | -$20.95 M(+15.3%) | -$76.37 M(+5.5%) |
| Sept 2018 | - | -$18.18 M(-10.5%) | -$72.37 M(+5.6%) |
| June 2018 | - | -$20.30 M(+19.8%) | -$68.51 M(+6.6%) |
| Mar 2018 | - | -$16.95 M(-0.0%) | -$64.29 M(+7.6%) |
| Dec 2017 | -$59.75 M(+129.2%) | -$16.95 M(+18.5%) | -$59.75 M(+39.6%) |
| Sept 2017 | - | -$14.31 M(-11.0%) | -$42.80 M(+50.2%) |
| June 2017 | - | -$16.08 M(+29.7%) | -$28.48 M(+129.7%) |
| Mar 2017 | - | -$12.40 M | -$12.40 M |
| Dec 2016 | -$26.07 M | - | - |
FAQ
- What is Telesis Bio annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Telesis Bio?
- What is Telesis Bio annual EBITDA year-on-year change?
- What is Telesis Bio quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Telesis Bio?
- What is Telesis Bio quarterly EBITDA year-on-year change?
- What is Telesis Bio TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Telesis Bio?
- What is Telesis Bio TTM EBITDA year-on-year change?
What is Telesis Bio annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of TBIO is -$29.43 M
What is the all time high annual EBITDA for Telesis Bio?
Telesis Bio all-time high annual earnings before interest, taxes, depreciation & amortization is $2.53 M
What is Telesis Bio annual EBITDA year-on-year change?
Over the past year, TBIO annual earnings before interest, taxes, depreciation & amortization has changed by +$13.46 M (+31.38%)
What is Telesis Bio quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of TBIO is -$9.53 M
What is the all time high quarterly EBITDA for Telesis Bio?
Telesis Bio all-time high quarterly earnings before interest, taxes, depreciation & amortization is $31.70 M
What is Telesis Bio quarterly EBITDA year-on-year change?
Over the past year, TBIO quarterly earnings before interest, taxes, depreciation & amortization has changed by -$816.00 K (-9.37%)
What is Telesis Bio TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of TBIO is -$28.79 M
What is the all time high TTM EBITDA for Telesis Bio?
Telesis Bio all-time high TTM earnings before interest, taxes, depreciation & amortization is $51.80 M
What is Telesis Bio TTM EBITDA year-on-year change?
Over the past year, TBIO TTM earnings before interest, taxes, depreciation & amortization has changed by +$3.45 M (+10.71%)